Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Jinyouli, PEG-rhG-CSF, Pegfilgrastim Biosimilar (CSPC Pharmaceutical Group Ltd.) + [4] |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (21 Oct 2011), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neutropenia | China | 21 Oct 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Clinical | China | 01 Aug 2020 | |
Lymphoma | Clinical | China | 01 Aug 2020 |
Not Applicable | 337 | (对照组) | qplbcxpmus(oaurehpufu) = kecplfiduj yuaowslwii (wulewdydlu ) View more | - | 19 Sep 2020 | ||
(治疗A组) | qplbcxpmus(oaurehpufu) = gzrmpwxlkf yuaowslwii (wulewdydlu ) View more | ||||||
Not Applicable | Breast Cancer Adjuvant | 96 | ihzszxljuz(ijrabhssmj) = nypysvwkdh xnshbwwsfk (jtkqahzfyz ) View more | Positive | 25 May 2020 | ||
zeezbtustn(xqejvoeuyz) = aifymdeite cemxpsiopq (epjsthbmrr ) View more |